Journal ArticleClin Infect Dis · June 27, 2024
Immunoassays designed to detect SARS-CoV-2 protein antigens (Ag) are commonly used to diagnose COVID-19. The most widely used tests are lateral flow assays that generate results in approximately 15 minutes for diagnosis at the point-of-care. Higher through ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 27, 2024
Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19) and for identifying asymptomatic carriage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The number of available SARS-CoV- ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Microbiol · June 12, 2024
We identified 23 cases of Mycobacterium immunogenum respiratory acquisition linked to a colonized plumbing system at a new hospital addition. We conducted a genomic and epidemiologic investigation to assess for clonal acquisition of M. immunogenum from hos ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2024
Mollicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung transplantation; however, understanding of the epidemiology and outcomes of these infections remains limited. We conducted a single-center retrospective ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Microbiol · August 23, 2023
Research on the COVID-19 pandemic revealed a disproportionate burden of COVID-19 infection and death among underserved populations and exposed low rates of SARS-CoV-2 testing in these communities. A landmark National Institutes of Health (NIH) funding init ...
Full textOpen AccessLink to itemCite
Journal ArticleFront Public Health · 2023
INTRODUCTION: The COVID-19 pandemic focused attention on healthcare disparities and inequities faced by individuals within marginalized and structurally disadvantaged groups in the United States. These individuals bore the heaviest burden across this pande ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Microbiol · November 18, 2021
The Burkholderia cepacia complex (BCC) is known for causing serious lung infections in people with cystic fibrosis (CF). These infections can require lung transplantation, eligibility for which may be guided by antimicrobial susceptibility testing (AST). W ...
Full textLink to itemCite
Journal ArticleExpert Rev Mol Diagn · October 2021
Introduction: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged as a novel viral agent that quickly spread worldwide. SARS-CoV-2 is responsible for the human coronavirus disease 2019 (COVID-19) which has claimed hundreds of thousands ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 23, 2021
BACKGROUND: Immunoassays designed to detect SARS-CoV-2 protein antigens are now commercially available. The most widely used tests are rapid lateral flow assays that generate results in approximately 15 minutes for diagnosis at the point-of-care. Higher th ...
Full textLink to itemCite
Journal ArticleInfect Control Hosp Epidemiol · March 2021
We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19 ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · January 22, 2021
BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens i ...
Full textOpen AccessLink to itemCite
Journal ArticleJAMA Netw Open · December 1, 2020
This diagnostic study describes an online tool created with actual severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus copy number data to help policy makers understand how pooled testing compares with single-sample testing in different popu ...
Full textOpen AccessLink to itemCite
Journal ArticleMMWR Morb Mortal Wkly Rep · November 20, 2020
On university campuses and in similar congregate environments, surveillance testing of asymptomatic persons is a critical strategy (1,2) for preventing transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). All students at D ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Infect Dis · November 9, 2020
During April and May 2020, we studied 20 patients hospitalized with coronavirus disease 2019 (COVID-19), their hospital rooms (fomites and aerosols), and their close contacts for molecular and culture evidence of severe acute respiratory syndrome coronavir ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 12, 2020
BACKGROUND: The availability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic testing has rapidly increased. Current assays use a variety of technologies, measure different classes of immunoglobulin or immunoglobulin combinations a ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 16, 2020
BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens i ...
Full textLink to itemCite